Clinical Significance of Surgical Resection Timing from Endoscopic Stenting for Left-Sided Large-Bowel Obstruction in Colorectal Cancer

• Published in: Digestive diseases and sciences 2022-10, Vol.67 (10), p.4895-4905
• Main Authors: Yoon, Sunseok, Pian, Guangzhe, Lim, Sun Gyo, Oh, Seung Yeop
• Format: Article
• Language: English
• Subjects: Biochemistry; Clinical significance; Colorectal cancer; Colorectal Neoplasms - complications; Colorectal Neoplasms - surgery; Disease-Free Survival; Endoscopy; Gastroenterology; Gastrointestinal diseases; Hepatology; Humans; Intestinal obstruction; Intestinal Obstruction - etiology; Intestinal Obstruction - surgery; Medical colleges; Medicine; Medicine & Public Health; Oncology; Original Article; Retrospective Studies; Stent (Surgery); Stents; Surgery; Transplant Surgery; Treatment Outcome
• ISSN: 0163-2116; 1573-2568
• DOI: 10.1007/s10620-021-07331-5

Background The optimal interval between self-expanding metallic stent (SEMS) insertion and surgery remains controversial in malignant left-sided large-bowel obstruction (MLLO), especially with respect to oncologic aspects. Aims The aim of this study is to examine whether the time interval to surgery is related to oncologic outcomes. Methods Prospectively collected database of MLLO between January 2005 and December 2017 were reviewed. They were divided according to established cut-off value of 14 days for the time interval to surgery. The two groups (early and late groups) were compared with respect to disease-free survival (DFS) and overall survival (OS). Additional subgroup analysis was performed using the established cut-off values for patients with stage II and III tumors. Results A total of 149 patients underwent surgery after SEMS insertion. There were no significant differences between the early and late groups in the 5-year DFS (78.0% vs 72.4%; P  = 0.513) and the OS (74.2% vs 75.7%; P  = 0.864) rates in all MLLO. Subgroup analysis showed that there were significant differences between the two groups for DFS and OS in stage II MLLO. The multivariate Cox regression analysis in stage II MLLO demonstrated that the time to surgery was a prognostic factor for DFS (HR, 2.051; 95% CI, 1.528–42.136; P  = 0.014) and for OS (HR, 4.947; 95% CI, 1.520–16.107; P  = 0.008). Conclusions The time to surgery was demonstrated not to be a significant prognostic factor in all MLLO. However, it was a prognostic factor for patients with stage II MLLO.